| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.005 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.13 | 0.006 |